Dr Reddys Laboratories Stock Z Score
| RDY Stock | USD 13.60 0.39 2.79% |
RDY | Z Score |
Dr Reddys Laboratories Company Z Score Analysis
Dr Reddys' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
RDY Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Dr Reddys is extremely important. It helps to project a fair market value of RDY Stock properly, considering its historical fundamentals such as Z Score. Since Dr Reddys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dr Reddys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dr Reddys' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
Based on the company's disclosures, Dr Reddys Laboratories has a Z Score of 0.0. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.
Dr Reddys ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Dr Reddys' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Dr Reddys' managers, analysts, and investors.Environmental | Governance | Social |
Dr Reddys Institutional Holders
Institutional Holdings refers to the ownership stake in Dr Reddys that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Dr Reddys' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Dr Reddys' value.| Shares | Bank Of America Corp | 2024-09-30 | 858.8 K | Goldman Sachs Group Inc | 2024-09-30 | 556 K | Allspring Global Investments Holdings, Llc | 2024-12-31 | 534.3 K | Allianz Asset Management Ag | 2024-12-31 | 475.4 K | Gqg Partners Llc | 2024-09-30 | 437 K | Rhumbline Advisers | 2024-12-31 | 430.1 K | Bnp Paribas Arbitrage, Sa | 2024-09-30 | 409.4 K | Healthcare Of Ontario Pension Plan Trust Fund | 2024-09-30 | 343.8 K | Man Group Plc | 2024-09-30 | 208.5 K | Robeco Institutional Asset Management Bv | 2024-12-31 | 11.4 M | Fisher Asset Management, Llc | 2024-12-31 | 2.5 M |
RDY Fundamentals
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 11.39 B | ||||
| Shares Outstanding | 833.12 M | ||||
| Shares Owned By Insiders | 0.03 % | ||||
| Shares Owned By Institutions | 14.96 % | ||||
| Number Of Shares Shorted | 15.9 M | ||||
| Price To Earning | 31.58 X | ||||
| Price To Book | 3.10 X | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 279.16 B | ||||
| Gross Profit | 184.65 B | ||||
| EBITDA | 88.42 B | ||||
| Net Income | 55.68 B | ||||
| Cash And Equivalents | 2.93 B | ||||
| Cash Per Share | 208.58 X | ||||
| Total Debt | 20.02 B | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 1.98 X | ||||
| Book Value Per Share | 381.36 X | ||||
| Cash Flow From Operations | 45.43 B | ||||
| Short Ratio | 7.51 X | ||||
| Earnings Per Share | 0.74 X | ||||
| Price To Earnings To Growth | 4.51 X | ||||
| Target Price | 15.58 | ||||
| Number Of Employees | 27.05 K | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 11.49 B | ||||
| Total Asset | 387.52 B | ||||
| Retained Earnings | 265.26 B | ||||
| Working Capital | 152.01 B | ||||
| Current Asset | 1.81 B | ||||
| Current Liabilities | 976 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.72 % | ||||
| Net Asset | 387.52 B | ||||
| Last Dividend Paid | 8.0 |
About Dr Reddys Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dr Reddys Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Reddys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Reddys Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for RDY Stock Analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.